Novartis Abandons Heart Drug After Surprising Failure in Key Study
· bloomberg.com · popularity 40/100 · 0 similar stories today
Read the original at bloomberg.com →
Summary
Novartis AG is largely abandoning an experimental drug analysts once considered a potential blockbuster after a study found it had little promise for …
Found in: Bloomberg. Rating basis: single outlet; outlet tier 5; 1 feeds; feed position 1.